PE20030356A1 - Isoxazolopiridinona - Google Patents

Isoxazolopiridinona

Info

Publication number
PE20030356A1
PE20030356A1 PE2002000734A PE2002000734A PE20030356A1 PE 20030356 A1 PE20030356 A1 PE 20030356A1 PE 2002000734 A PE2002000734 A PE 2002000734A PE 2002000734 A PE2002000734 A PE 2002000734A PE 20030356 A1 PE20030356 A1 PE 20030356A1
Authority
PE
Peru
Prior art keywords
phenyl
alkyl
dialkyl
pidyridin
ilo
Prior art date
Application number
PE2002000734A
Other languages
English (en)
Spanish (es)
Inventor
Samuel Hintermann
Bastian Hengerer
Krosigk Ulrike Von
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20030356A1 publication Critical patent/PE20030356A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PE2002000734A 2001-08-15 2002-08-14 Isoxazolopiridinona PE20030356A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0119911.6A GB0119911D0 (en) 2001-08-15 2001-08-15 Organic Compounds

Publications (1)

Publication Number Publication Date
PE20030356A1 true PE20030356A1 (es) 2003-05-14

Family

ID=9920454

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000734A PE20030356A1 (es) 2001-08-15 2002-08-14 Isoxazolopiridinona

Country Status (24)

Country Link
US (1) US7087756B2 (https=)
EP (1) EP1418912B1 (https=)
JP (1) JP2005501847A (https=)
KR (1) KR20040029429A (https=)
CN (1) CN100384418C (https=)
AR (1) AR036351A1 (https=)
AT (1) ATE355059T1 (https=)
BR (1) BR0211903A (https=)
CA (1) CA2454762A1 (https=)
CO (1) CO5560566A2 (https=)
DE (1) DE60218484T2 (https=)
EC (1) ECSP044971A (https=)
ES (1) ES2282467T3 (https=)
GB (1) GB0119911D0 (https=)
HU (1) HUP0401325A3 (https=)
IL (1) IL160018A0 (https=)
MX (1) MXPA04001419A (https=)
NO (1) NO20040659L (https=)
PE (1) PE20030356A1 (https=)
PL (1) PL366848A1 (https=)
PT (1) PT1418912E (https=)
RU (1) RU2004107847A (https=)
WO (1) WO2003015780A2 (https=)
ZA (1) ZA200400525B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2451057A1 (en) * 2001-06-14 2002-12-27 Banyu Pharmaceutical Co., Ltd. Novel isoxazolopyridone derivatives and use thereof
BRPI0511099A (pt) * 2004-05-14 2007-12-26 Irm Llc compostos e composições como moduladores de ppar
RU2008135762A (ru) * 2006-02-16 2010-03-27 Де МакЛин Хоспитал Корпорейшн (US) Способы и композиции для лечения болезни паркинсона
US7666888B2 (en) 2006-07-20 2010-02-23 Amgen Inc. Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1
FR2906250B1 (fr) * 2006-09-22 2008-10-31 Sanofi Aventis Sa Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
FR2933609B1 (fr) * 2008-07-10 2010-08-27 Fournier Lab Sa Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson.
CA2749585A1 (en) 2009-01-13 2010-07-22 Van Andel Research Institute Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
FR2950053B1 (fr) 2009-09-11 2014-08-01 Fournier Lab Sa Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
FR2955110A1 (fr) 2010-01-08 2011-07-15 Fournier Lab Sa Nouveaux derives de type pyrrolopyridine benzoique
DE102011085038A1 (de) 2011-10-21 2013-04-25 Tesa Se Verfahren zur Kapselung einer elektronischen Anordnung
JP2016531852A (ja) 2013-09-25 2016-10-13 ヴァン アンデル リサーチ インスティテュート 非常に強力なグルココルチコイド
KR20170033630A (ko) 2015-09-17 2017-03-27 (주)다올 도로용 경계블럭
CN110382033B (zh) 2016-10-14 2022-04-15 范安德尔研究所 用于设计高效力糖皮质激素的结构与机制

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7602542L (sv) 1975-03-14 1976-09-15 Sandoz Ag 3-(alfa-iminobensyl)-4-hydroxi-2(lh)-pyridoner
US4064251A (en) 1976-06-25 1977-12-20 Sandoz, Inc. Substituted hydroxy pyridones
US4049813A (en) * 1976-07-15 1977-09-20 Sandoz, Inc. Substituted isoxazolo pyridinones
DE2801190A1 (de) 1977-01-19 1978-07-20 Sandoz Ag 3-(alpha-iminobenzyl)-4-hydroxy-2(1h)- pyridon-derivat
US4238616A (en) 1977-01-19 1980-12-09 Sandoz, Inc. 3-(Substituted)phenyl-5-(β-hydroxyphenethyl)-N-(alkyl)-isoxazole-4-carboxamides
US4113727A (en) * 1977-04-26 1978-09-12 Sandoz, Inc. Process for the preparation of substituted isoxazolo[4,5-c]pyridin-4-(5H)-ones
CA2451057A1 (en) * 2001-06-14 2002-12-27 Banyu Pharmaceutical Co., Ltd. Novel isoxazolopyridone derivatives and use thereof

Also Published As

Publication number Publication date
CA2454762A1 (en) 2003-02-27
WO2003015780A8 (en) 2004-05-21
MXPA04001419A (es) 2004-05-27
US20040248893A1 (en) 2004-12-09
CO5560566A2 (es) 2005-09-30
JP2005501847A (ja) 2005-01-20
WO2003015780A2 (en) 2003-02-27
ATE355059T1 (de) 2006-03-15
CN1635889A (zh) 2005-07-06
RU2004107847A (ru) 2005-05-10
ECSP044971A (es) 2004-03-23
DE60218484D1 (de) 2007-04-12
ES2282467T3 (es) 2007-10-16
EP1418912B1 (en) 2007-02-28
US7087756B2 (en) 2006-08-08
BR0211903A (pt) 2004-09-21
HUP0401325A3 (en) 2005-09-28
HUP0401325A2 (hu) 2004-10-28
NO20040659D0 (no) 2004-02-13
DE60218484T2 (de) 2007-11-15
WO2003015780A3 (en) 2003-11-13
EP1418912A2 (en) 2004-05-19
KR20040029429A (ko) 2004-04-06
NO20040659L (no) 2004-02-13
CN100384418C (zh) 2008-04-30
PL366848A1 (en) 2005-02-07
ZA200400525B (en) 2005-04-01
IL160018A0 (en) 2004-06-20
AR036351A1 (es) 2004-09-01
PT1418912E (pt) 2007-05-31
GB0119911D0 (en) 2001-10-10

Similar Documents

Publication Publication Date Title
PE20030356A1 (es) Isoxazolopiridinona
TWI255807B (en) Therapeutic agents
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
PE20081135A1 (es) Derivados que contienen sulfamoilo y sus usos
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
PE20050480A1 (es) Acido [2-(8,9-dioxo-2,6-diazabiciclo [5.2.0] non-1(7)-en-2-il)alquil]fosfonico y derivados
BRPI0407329A (pt) Derivados de pirimidina para a prevenção de infecção de hiv
ECSP066383A (es) Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias
TNSN04165A1 (en) Substituted hydroxyethylamines
PE20120355A1 (es) DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1
PE20090210A1 (es) Compuestos derivados de pirazolo pirimidina como inhibidores de jak quinasa
PE20060589A1 (es) FENILAMINOTIAZOLES SUSTITUIDOS COMO AGONISTAS DE ADENOSINA A1 Y A2b
AU2003284632A1 (en) Isoquinoline compounds and medicinal use thereof
SG151260A1 (en) 5-substituted-2-phenylamino-benzamides as mek inhibitors
AR040278A1 (es) Ligandos del receptor de glucocorticoides para el tratamiento de trastornos metabolicos
PE20020210A1 (es) Indoloquinazolinonas como inhibidores de poli(adp-ribosa)polimerasa (parp)
BRPI0111911B8 (pt) preparado aplicável por via oral compreendendo ciprofloxacina
BRPI0518231A2 (pt) derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica
PE20142421A1 (es) Fenilimidazopirazoles sustituidos y su uso
SE0302756D0 (sv) Novel Compounds
BR0305041A (pt) Compostos orgânicos
MXPA04003479A (es) Novedosos derivados de 4-fenil-4[1h-imidazol-2-il]piperidina sustituida y su uso como agonistas selectivos no peptidicos de opiodes delta.
CY1112638T1 (el) Χρηση των παραγωγων ινδολιου ως ενεργοποιητες νurr-1 για την θεραπεια νοσου ραrκινsον
PE20050393A1 (es) Compuestos de benzopirano para uso en el tratamiento y la prevencion de afecciones relacionadas con la inflamacion
PE20100737A1 (es) Nuevos compuestos

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed